Lysates of bacteria [Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae B, Neisseria catarrhalis] (Bacteriolysates [Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae B, Neisseria catarrhalis])

Combined immunostimulating drug of bacterial origin for sublingual (sublingual) administration. It is a multivalent antigenic complex, which includes lysates of bacteria - the most common pathogens of respiratory infections. Lysates, which are part of the drug, are obtained by mechanical action. Like other immunostimulants of bacterial origin of the second generation, the drug has a nonspecific immunostimulating and specific vaccinating action.

Stimulates both the local cellular and humoral immune response, and the systemic immune response. Activates phagocytosis, increases the content of lysozyme in saliva, helps increase the number of immunocompetent cells. Increases the functional and metabolic activity of macrophages (including alveolar) and polymorphonuclear leukocytes. As a result of treatment with the drug, the frequency, severity and duration of acute infections of the respiratory tract are reduced; there is relief and leveling of symptoms such as fever, cough, shortness of breath,decreases the need for antibacterial and anti-inflammatory therapy; in patients with chronic diseases of the respiratory tract, the drug also prevents exacerbations.